Evidence map›Paper›PMID 31488083›Full record

ArticleBMC cancer2019

INPART - a psycho-oncological intervention for partners of patients with haemato-oncological disease - study protocol.

Inga Lorenz, Daniela Bodschwinna, Nina Hallensleben, Hartmut Döhner, Dietger Niederwieser, Tanja Zimmermann, Anja Mehnert, Harald Gündel, Jochen Ernst, Klaus Hoenig

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Inga LorenzDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Daniela BodschwinnaDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Nina HallenslebenDepartment of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany.
Hartmut DöhnerComprehensive Cancer Center Ulm, Ulm, Germany.
Dietger NiederwieserDepartment of Haematology and Oncology, University Medical Center Leipzig, Leipzig, Germany.
Tanja ZimmermannDepartment of Psychosomatic Medicine and Psychotherapy, Hannover University Medical School, Hannover, Germany.
Anja MehnertDepartment of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany.
Harald GündelDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Jochen ErnstDepartment of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany.
Klaus HoenigDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. klaus.hoenig@uniklinik-ulm.de.

Funding

José Carreras Leukämie-Stiftung DJCLS 23R/2016
6 · The paper itself

Abstract

backgroundSuffering from cancer confronts both the patient and their partner with a number of psychosocial challenges in various aspects of their life. These challenges may differentially impact on quality of life, coping ability and compliance to treatment. This especially holds true for haemato-oncological diseases. To date, psychological interventions have predominantly been developed for oncological patients however specific interventions for partners of haemato-oncological patients are rare. In this study we aim to conduct a psycho-oncological group-intervention for partners of patients with haemato-oncological diseases. The aim of the intervention is to significantly reduce symptoms of depression and anxiety in the partners and the patient, as well as enhancing dyadic coping.

methodsThe design of the INPART-study is an unblinded, randomised controlled trial with 2 treatment conditions (experimental and control) and assessments at baseline, 3 and 6 months. It will be conducted at three study centres: the university medical centre's in Leipzig, Hannover and Ulm. The outcome criteria will be a reduction in depressive and anxiety symptoms as well as an improvement of dyadic coping. DISCUSSION: This trial shall provide information regarding the efficiency of a psycho-oncological intervention for partners of patients with haemato-oncological diseases and give references to the possible outcome in terms of dyadic coping and the reduction of mental strain. The study was supported by a grant from the German José Carreras Leukaemia Foundation.

trial registrationISRCTN16085028 ; 20/03/2019.

Indexed as

Adaptation, PsychologicalAnalysis of VarianceAnxietyDepressionEarly Medical InterventionFeasibility StudiesFemaleFollow-Up StudiesGermanyHematologic NeoplasmsHumansMaleMulticenter Studies as TopicQuality of LifeRandomized Controlled Trials as TopicSample SizeAnxietyCancerDepressionDyadic copingGroup-interventionPartnerPsycho-oncologyQuality of lifeSpouse

Identifiers

PMID31488083
PMCPMC6729088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.